June 29, 2010 (Orlando, Florida) — Amid the stormy debate over the safety of rosiglitazone (Avandia, GlaxoSmithKline), one that may reach a climax of sorts when the drug is scrutinized yet again by an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results